HomeQNCX • NASDAQ
add
Quince Therapeutics Inc
Previous close
$0.79
Day range
$0.75 - $0.82
Year range
$0.51 - $1.43
Market cap
34.53M USD
Avg Volume
67.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 8.84M | 58.35% |
Net income | -27.73M | -467.52% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -8.80M | -57.59% |
Effective tax rate | -0.13% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 59.44M | -32.11% |
Total assets | 134.83M | 51.77% |
Total liabilities | 87.86M | 4,401.08% |
Total equity | 46.97M | — |
Shares outstanding | 43.28M | — |
Price to book | 0.73 | — |
Return on assets | -15.03% | — |
Return on capital | -29.55% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -27.73M | -467.52% |
Cash from operations | -8.74M | -128.35% |
Cash from investing | -4.98M | 75.51% |
Cash from financing | 35.00K | 34.62% |
Net change in cash | -13.92M | 42.14% |
Free cash flow | -5.19M | -172.75% |
About
Founded
2012
Headquarters
Website
Employees
32